methoctramine has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arias, ME; Asencio-Leal, L; Buelvas, N; Jara, JA; López-Muñoz, RA; Martin-Martin, A; Muñoz-Uribe, M; Rojas-Fernández, A; Tapia, JC; Ugarte-Vio, I | 1 |
| Chen, H; Gu, X; Lu, Q; Xu, L; Zhang, C; Zhao, Q | 1 |
2 other study(ies) available for methoctramine and Lung Neoplasms
| Article | Year |
|---|---|
Indomethacin Induces Spermidine/Spermine-N
Topics: Acetyltransferases; Antineoplastic Agents; CDC2 Protein Kinase; Cyclooxygenase 2; Humans; Indomethacin; Lung Neoplasms; Nucleolin; Oxidoreductases; Peroxisome Proliferator-Activated Receptors; Polyamine Oxidase | 2023 |
Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC).
Topics: Acetylcholine; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Diamines; Epithelial-Mesenchymal Transition; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, Muscarinic M2; Signal Transduction | 2015 |